Paul K. Paik
- Oncology top 0.5%
- Lung Cancer Research Studies 57
- Colorectal Cancer Treatments and Studies 11
- Peptidase Inhibition and Analysis 8
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 117
- Lung Cancer Diagnosis and Treatment 50
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 14
- Hepatology top 5%
- Molecular Biology top 5%
- Fibroblast Growth Factor Research 7
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 13
- Co-authors
- Marc LadanyiMark G. KrisGregory J. RielyMaria E. ArcilaCamelia S. SimaNatasha RekhtmanMaureen F. ZakowskiAlexander Drilon
- Journals
- Journal of Clinical Oncology (42 papers)Annals of Oncology (23 papers)Journal of Thoracic Oncology (19 papers)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Paul K. Paik
148 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 3.0k
- Pulmonary and Respiratory Medicine 3.5k
- Cancer Research 1.1k
- Hepatology 272
- Molecular Biology 2.2k
Countries citing papers authored by Paul K. Paik
This map shows the geographic impact of Paul K. Paik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul K. Paik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul K. Paik more than expected).
Fields of papers citing papers by Paul K. Paik
This network shows the impact of papers produced by Paul K. Paik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul K. Paik. The network helps show where Paul K. Paik may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul K. Paik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 14 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 10 | |
| 10 | 2023 | 0 | |
| 11 | 2022 | 13 | |
| 12 | 2020 | 10 | |
| 13 | 2017 | 115 | |
| 14 | Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsetsbreakdown → | 2016 | 325 |
| 15 | 2015 | 111 | |
| 16 | Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skippingbreakdown → | 2015 | 423 |
| 17 | 2012 | 289 | |
| 18 | Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS -Mutant Cancersbreakdown → | 2012 | 493 |
| 19 | 2011 | 162 | |
| 20 | Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutationsbreakdown → | 2011 | 503 |
About Paul K. Paik
Paul K. Paik is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Hepatology and Molecular Biology, having authored 155 papers that have together received 5.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (117 papers), Lung Cancer Research Studies (57 papers), Lung Cancer Diagnosis and Treatment (50 papers), Cancer Genomics and Diagnostics (14 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Colorectal Cancer Treatments and Studies (11 papers), Peptidase Inhibition and Analysis (8 papers) and Fibroblast Growth Factor Research (7 papers). The work is most often cited by research in Oncology (3.0k citations), Pulmonary and Respiratory Medicine (3.5k citations), Cancer Research (1.1k citations), Hepatology (272 citations) and Molecular Biology (2.2k citations). Paul K. Paik has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Marc Ladanyi, Mark G. Kris, Gregory J. Riely, Maria E. Arcila, Camelia S. Sima, Natasha Rekhtman, Maureen F. Zakowski, Alexander Drilon, Jamie E. Chaft and Vincent A. Miller. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Clinical Cancer Research and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.